ID   KA152_MESMA             Reviewed;          59 AA.
AC   Q8I0L5;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   11-DEC-2019, entry version 74.
DE   RecName: Full=Potassium channel toxin alpha-KTx 15.2 {ECO:0000305};
DE   AltName: Full=BmTX3 {ECO:0000303|PubMed:11457451};
DE   AltName: Full=BmTX3A {ECO:0000303|PubMed:14599291};
DE   Flags: Precursor;
OS   Mesobuthus martensii (Manchurian scorpion) (Buthus martensii).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
OC   Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
OX   NCBI_TaxID=34649;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], PROTEIN SEQUENCE OF 23-59,
RP   SYNTHESIS OF 23-59, FUNCTION, PYROGLUTAMATE FORMATION AT GLN-23, AND
RP   3D-STRUCTURE MODELING.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=14599291; DOI=10.1042/bj20031324;
RA   Huys I., Xu C.-Q., Wang C.-Z., Vacher H., Martin-Eauclaire M.-F.,
RA   Chi C.-W., Tytgat J.;
RT   "BmTx3, a scorpion toxin with two putative functional faces separately
RT   active on A-type K+ and HERG currents.";
RL   Biochem. J. 378:745-752(2004).
RN   [2]
RP   PROTEIN SEQUENCE OF 23-59, SYNTHESIS, FUNCTION, MASS SPECTROMETRY,
RP   SUBCELLULAR LOCATION, AND PYROGLUTAMATE FORMATION AT GLN-23.
RC   TISSUE=Venom;
RX   PubMed=11457451; DOI=10.1016/s0014-5793(01)02620-5;
RA   Vacher H., Romi-Lebrun R., Mourre C., Lebrun B., Kourrich S., Masmejean F.,
RA   Nakajima T., Legros C., Crest M., Bougis P.E., Martin-Eauclaire M.-F.;
RT   "A new class of scorpion toxin binding sites related to an A-type K+
RT   channel: pharmacological characterization and localization in rat brain.";
RL   FEBS Lett. 501:31-36(2001).
RN   [3]
RP   FUNCTION, AND MUTAGENESIS OF 58-TYR-PRO-59.
RX   PubMed=12473099; DOI=10.1046/j.1432-1033.2002.03294.x;
RA   Vacher H., Alami M., Crest M., Possani L.D., Bougis P.E.,
RA   Martin-Eauclaire M.-F.;
RT   "Expanding the scorpion toxin alpha-KTX 15 family with AmmTX3 from
RT   Androctonus mauretanicus.";
RL   Eur. J. Biochem. 269:6037-6041(2002).
RN   [4]
RP   FUNCTION.
RX   PubMed=16987219; DOI=10.1111/j.1460-9568.2006.05020.x;
RA   Vacher H., Diochot S., Bougis P.E., Martin-Eauclaire M.F., Mourre C.;
RT   "Kv4 channels sensitive to BmTX3 in rat nervous system: autoradiographic
RT   analysis of their distribution during brain ontogenesis.";
RL   Eur. J. Neurosci. 24:1325-1340(2006).
RN   [5]
RP   FUNCTION.
RX   PubMed=23440961; DOI=10.1113/jphysiol.2012.248831;
RA   Maffie J.K., Dvoretskova E., Bougis P.E., Martin-Eauclaire M.F., Rudy B.;
RT   "Dipeptidyl-peptidase-like-proteins confer high sensitivity to the scorpion
RT   toxin AmmTX3 to Kv4-mediated A-type K+ channels.";
RL   J. Physiol. (Lond.) 591:2419-2427(2013).
RN   [6]
RP   STRUCTURE BY NMR OF 23-59, DISULFIDE BONDS, AND MUTAGENESIS OF
RP   58-TYR-PRO-59.
RX   PubMed=12637022; DOI=10.1016/s1570-9639(02)00557-5;
RA   Vacher H., Romi-Lebrun R., Crest M., Masmejean F., Bougis P.E., Darbon H.,
RA   Martin-Eauclaire M.-F.;
RT   "Functional consequences of deleting the two C-terminal residues of the
RT   scorpion toxin BmTX3.";
RL   Biochim. Biophys. Acta 1646:152-156(2003).
CC   -!- FUNCTION: Blocks both human ERG1/Kv11.1/KCNH2 potassium channels (in a
CC       reversible manner) (PubMed:14599291) and A-type voltage-gated potassium
CC       channels Kv4/KCND (in an irreversible manner) (PubMed:11457451,
CC       PubMed:12473099, PubMed:12637022). The presence of the Kv4-associated
CC       proteins DPP6 or DPP10 is mandatory to have high-affinity blockade of
CC       Kv4.2/KCND2 and Kv4.3/KCND3 channels (By similarity). In contrast, the
CC       presence of the Kv4-associated protein KChIP1/KCNIP1 does not enhance
CC       the affinity blockade (By similarity). May dispose of two functional
CC       faces (A and B); the two basic residues (Arg-40 and Lys-41) on the
CC       alpha-helix side of the peptide that blocks the hERG current (face A)
CC       and the typical dyad through which it blocks A-type currents on the
CC       beta-sheet side (face B) (PubMed:14599291). In adult rat brain, it
CC       binds to sites in the striatum, hippocampus, superior colliculus, and
CC       cerebellum. It shares the same target in rat brain than AaTX1 (AC
CC       Q867F4) and AmmTX3 (AC P60208). In DPP6 knockout mice, A-type currents
CC       are much less affected by the toxin than in wild-type mice
CC       (PubMed:23440961). {ECO:0000250|UniProtKB:P60208,
CC       ECO:0000269|PubMed:11457451, ECO:0000269|PubMed:12473099,
CC       ECO:0000269|PubMed:14599291, ECO:0000269|PubMed:23440961}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:11457451}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland. {ECO:0000305}.
CC   -!- DOMAIN: Has the structural arrangement of an alpha-helix connected to a
CC       beta-sheet by disulfide bonds (CSalpha/beta).
CC       {ECO:0000250|UniProtKB:P84777}.
CC   -!- MASS SPECTROMETRY: Mass=3751.8; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:11457451};
CC   -!- MISCELLANEOUS: Has no effect on Kv1.1/KCNA1, Kv1.2/KCNA2, Kv1.3/KCNA3,
CC       Kv7.1/KCNQ1, Kv7.1/KCNQ1+minK, and on Kir2.1/KCNJ2.
CC       {ECO:0000269|PubMed:14599291}.
CC   -!- SIMILARITY: Belongs to the short scorpion toxin superfamily. Potassium
CC       channel inhibitor family. Alpha-KTx 15 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF541980; AAN34656.1; -; mRNA.
DR   EMBL; AY156725; AAN85572.1; -; Genomic_DNA.
DR   SMR; Q8I0L5; -.
DR   TCDB; 8.B.8.1.2; the Alpha-ktx15 scorpion toxin (Alpha-ktx15) family.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0008200; F:ion channel inhibitor activity; IEA:InterPro.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0009405; P:pathogenesis; IEA:InterPro.
DR   Gene3D; 3.30.30.10; -; 1.
DR   InterPro; IPR036574; Scorpion_toxin-like_sf.
DR   InterPro; IPR001947; Scorpion_toxinS_K_inh.
DR   Pfam; PF00451; Toxin_2; 1.
DR   SUPFAM; SSF57095; SSF57095; 1.
DR   PROSITE; PS01138; SCORP_SHORT_TOXIN; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Ion channel impairing toxin;
KW   Neurotoxin; Potassium channel impairing toxin; Pyrrolidone carboxylic acid;
KW   Secreted; Signal; Toxin; Voltage-gated potassium channel impairing toxin.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000269|PubMed:11457451,
FT                   ECO:0000269|PubMed:14599291"
FT   CHAIN           23..59
FT                   /note="Potassium channel toxin alpha-KTx 15.2"
FT                   /evidence="ECO:0000269|PubMed:11457451,
FT                   ECO:0000269|PubMed:14599291"
FT                   /id="PRO_0000035319"
FT   SITE            28
FT                   /note="Hot spot residue in hERG blocking currents"
FT                   /evidence="ECO:0000305|PubMed:14599291"
FT   SITE            40
FT                   /note="Hot spot basic residue in hERG blocking currents"
FT                   /evidence="ECO:0000305|PubMed:14599291"
FT   SITE            41
FT                   /note="Hot spot basic residue in hERG blocking currents"
FT                   /evidence="ECO:0000305|PubMed:14599291"
FT   SITE            49
FT                   /note="Basic residue of the functional dyad"
FT                   /evidence="ECO:0000250"
FT   SITE            58
FT                   /note="Aromatic residue of the functional dyad"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         23
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000269|PubMed:11457451,
FT                   ECO:0000269|PubMed:14599291"
FT   DISULFID        30..50
FT                   /evidence="ECO:0000269|PubMed:12637022"
FT   DISULFID        35..55
FT                   /evidence="ECO:0000269|PubMed:12637022"
FT   DISULFID        39..57
FT                   /evidence="ECO:0000269|PubMed:12637022"
FT   MUTAGEN         58..59
FT                   /note="Missing: Decrease in blocking of A-type voltage-
FT                   gated potassium channels, loss of inhibition of Kv4.1/KCND1
FT                   and Kv4.3/KCND3."
FT                   /evidence="ECO:0000269|PubMed:12637022,
FT                   ECO:0000269|PubMed:16987219"
SQ   SEQUENCE   59 AA;  6206 MW;  4A3D46C865996652 CRC64;
     MKFSSIILLT LLICSMSKFG NCQVETNVKC QGGSCASVCR KAIGVAAGKC INGRCVCYP
//
